Coronary heart disease is a major public health problem, and even a small reduction in the number of adverse events will go a long way toward reducing morbidity and mortality, thereby cutting down the cost of health care significantly. Minimum intensity anticoagulation therapy as a primary preventive measure is a promising area that has been examined by MacCallum et al1 and has huge implications in terms of resource allocation.
Lankipalli R, Parameswaran H, Chemiti G. Minimum Intensity Anticoagulation Therapy as Primary Prevention Strategy. Arch Intern Med. 2001;161(7):1015-1016. doi: